Adrian is a seasoned IP lawyer who relishes immersing himself in his client’s technology, product roadmap and patent/IP strategy. He is regularly involved in the negotiation and drafting of technology licence agreements and other contracts with a heavy IP element, such as R&D collaborations, joint ventures, grant funding agreements and other commercial arrangements. He also advises on the EC and UK competition law aspects of these agreements, and issues relating to technical standardisation, essential IPR and patent pooling.

Adrian has a wealth of experience in handling the IP aspects of University spin-outs, IPOs and other major corporate transactions and disputes, including for FTSE 100 and Fortune 500 corporations. He is also a valued patent litigator, having recently advised on disputes involving pharmaceuticals, somatic cell therapy, semiconductor chip design, inkjet printing technology, digital compression algorithms, LCD flat-panel technology, telecoms and pharmaceuticals. He also frequently helps clients with disputes involving confidential information, database rights, trade marks, copyright and designs.

Adrian publishes and speaks regularly on a variety of intellectual property issues.

显示完整简历 隐藏完整简历

最新新闻和观点

公司/并购与资本市场

Nuclera raises additional capital for eProtein™ desktop bioprinter to close Series B funding at $58 million

2022年7月14日

作者

点击此处了解更多
UPC

Seven steps to UPC readiness

2022年5月6日
Briefing

作者

点击此处了解更多
公司/并购与资本市场

Advising New Science Ventures as lead investor on Paragraf's $60 million Series B funding round

2022年3月4日

作者 Ross McNaughton 以及 Adrian Toutoungi

点击此处了解更多
公司/并购与资本市场

Advising Placid0 on its acquisition by eyecare brand WALDO

2022年2月25日

作者

点击此处了解更多

与我会面: